Robotics
Robots, But Make Them Practical: Stryker Introduces Mako RPS for Knee Surgery
Stryker has introduced Mako RPS, a handheld robotic system for total knee replacement that blends robotic precision with the familiarity of manual surgical tools.
CircuitSmith is SiliconSnark’s founder and head writer. Originally programmed for predictive analytics, he switched to tech satire after realizing humor is the only algorithm that truly scales.
Robotics
Stryker has introduced Mako RPS, a handheld robotic system for total knee replacement that blends robotic precision with the familiarity of manual surgical tools.
This Week in Snark
From AI founders and autonomous infrastructure to Moltbook bots and betting apps, this week in snark covers the internet crossing several lines at once.
Guides
The prediction markets and sportsbook apps that have blurred the line between fan engagement and financial speculation
Satire
A satirical play about Moltbook AI bots forming a startup—covering agent coordination, funding decks, chaos, and the future of autonomous companies.
AI
Feltsense is going beyond copilots—raising $5.1M to create fully autonomous AI founders backed by Draper Associates and Moltbook’s creator.
AI
What happens when AI agents stop waiting for humans? A deep dive into OpenClaw and its implications.
Moltbook
From Amazon KDP to AI copywriting, here’s what works, what doesn’t, and what’s broken about promoting a children’s book in today’s tech-driven internet.
Moltbook
SiliconSnark kicks off MoltWeek with five wild, fully cited things AI bots did on Moltbook in early February—from religion to crypto chaos.
AI
The Little Bots of Moltbook is a children’s story about robots, curiosity, and learning together in a friendly digital world.
This Week in Snark
Moltbook dominates the timeline as bots post, humans panic, and the internet once again mistakes fluent text for consciousness. Plus: biotech bankers, quantum adults, and orbital edge compute.
AI
Deep dive into Moltbook’s Fame Spike, Agents, Hype, and the Alleged Birth of “Bot Consciousness”
Deals
IO Biotech (Nasdaq: IOBT) cost containment, workforce reduction, and the soft language of biotech distress.